Targeting Alternative Splicing as a Potential Therapy for Episodic Ataxia Type 2
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Alternative Splicing as a Potential Therapy for Episodic Ataxia Type 2
Authors
Keywords
-
Journal
Biomedicines
Volume 8, Issue 9, Pages 332
Publisher
MDPI AG
Online
2020-09-07
DOI
10.3390/biomedicines8090332
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
- (2020) Dan Wang et al. CELL
- Emerging Roles of Activity-Dependent Alternative Splicing in Homeostatic Plasticity
- (2020) Agnes Thalhammer et al. Frontiers in Cellular Neuroscience
- An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials
- (2019) Basil T. Darras et al. CNS DRUGS
- Disruption of splicing-regulatory elements using CRISPR/Cas9 rescues spinal muscular atrophy in human iPSCs and mice
- (2019) Jin-Jing Li et al. National Science Review
- Strategies for the CRISPR-Based Therapeutics
- (2019) Bin Li et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
- (2018) Silvana Konermann et al. CELL
- Exon-skipping advances for Duchenne muscular dystrophy
- (2018) Lucía Echevarría et al. HUMAN MOLECULAR GENETICS
- Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
- (2018) Eugenio Mercuri et al. NEUROMUSCULAR DISORDERS
- Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits
- (2018) Agnes Thalhammer et al. Jove-Journal of Visualized Experiments
- The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature
- (2018) E. Indelicato et al. EUROPEAN JOURNAL OF NEUROLOGY
- Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase
- (2018) Juanjuan Yuan et al. MOLECULAR CELL
- RNA Splicing and Disease: Animal Models to Therapies
- (2018) Matías Montes et al. TRENDS IN GENETICS
- RNA targeting with CRISPR–Cas13
- (2017) Omar O. Abudayyeh et al. NATURE
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
- (2017) Kathleen M. Schoch et al. NEURON
- The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy
- (2017) Constantin d’Ydewalle et al. NEURON
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
- (2017) S. Ryder et al. Orphanet Journal of Rare Diseases
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Alternative Splicing of P/Q-Type Ca 2+ Channels Shapes Presynaptic Plasticity
- (2017) Agnes Thalhammer et al. Cell Reports
- Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model
- (2017) Karima Relizani et al. Molecular Therapy-Nucleic Acids
- Mutation Spectrum in the CACNA1A Gene in 49 Patients with Episodic Ataxia
- (2017) Cèlia Sintas et al. Scientific Reports
- Genetic Variants Associated with Episodic Ataxia in Korea
- (2017) Kwang-Dong Choi et al. Scientific Reports
- Eye movement disorders are an early manifestation ofCACNA1Amutations in children
- (2016) Esther M Tantsis et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Intrathecal Injections in Children With Spinal Muscular Atrophy
- (2016) Manon Haché et al. JOURNAL OF CHILD NEUROLOGY
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- Splice-switching antisense oligonucleotides as therapeutic drugs
- (2016) Mallory A. Havens et al. NUCLEIC ACIDS RESEARCH
- Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
- (2016) K. Nishida et al. SCIENCE
- C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
- (2016) Omar O. Abudayyeh et al. SCIENCE
- mRNAtrans -splicing in gene therapy for genetic diseases
- (2016) Adeline Berger et al. Wiley Interdisciplinary Reviews-RNA
- Next-generation sequencing identifies novelCACNA1Agene mutations in episodic ataxia type 2
- (2016) Neven Maksemous et al. Molecular Genetics & Genomic Medicine
- Exon skipping therapy for Duchenne muscular dystrophy
- (2015) Ryszard Kole et al. ADVANCED DRUG DELIVERY REVIEWS
- CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms
- (2015) Lena Damaj et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers
- (2015) Aurélie Goyenvalle et al. NATURE MEDICINE
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature
- (2014) Wolfgang Nachbauer et al. JOURNAL OF NEUROLOGY
- A day in the life of the spliceosome
- (2014) A. Gregory Matera et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Genetics of Spinal Muscular Atrophy: Progress and Challenges
- (2014) Michelle A. Farrar et al. Neurotherapeutics
- Alternative-splicing-mediated gene expression
- (2014) Qianliang Wang et al. PHYSICAL REVIEW E
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders
- (2014) S. E. Soden et al. Science Translational Medicine
- Regulation of alternative splicing of tau exon 10
- (2014) Wei Qian et al. Neuroscience Bulletin
- Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing
- (2013) María Elena Avale et al. HUMAN MOLECULAR GENETICS
- Postnatal Loss of P/Q-Type Channels Confined to Rhombic-Lip-Derived Neurons Alters Synaptic Transmission at the Parallel Fiber to Purkinje Cell Synapse and Replicates Genomic Cacna1a Mutation Phenotype of Ataxia and Seizures in Mice
- (2013) T. Maejima et al. JOURNAL OF NEUROSCIENCE
- Dual Masking of Specific Negative Splicing Regulatory Elements Resulted in Maximal Exon 7 Inclusion of SMN2 Gene
- (2013) Peng Wen Pao et al. MOLECULAR THERAPY
- Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood
- (2013) Chihiro Ohba et al. NEUROGENETICS
- Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNA
- (2013) Sarah L. DeVos et al. Neurotherapeutics
- Inhibition of RNA Helicase Brr2 by the C-Terminal Tail of the Spliceosomal Protein Prp8
- (2013) S. Mozaffari-Jovin et al. SCIENCE
- Control of neuronal voltage-gated calcium ion channels from RNA to protein
- (2013) Diane Lipscombe et al. TRENDS IN NEUROSCIENCES
- Targeting RNA splicing for disease therapy
- (2013) Mallory A. Havens et al. Wiley Interdisciplinary Reviews-RNA
- Evidence-based path to newborn screening for duchenne muscular dystrophy
- (2012) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO)
- (2012) Simona Cavalieri et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Spliceosome-Mediated Trans-Splicing: The Therapeutic Cut and Paste
- (2012) Verena Wally et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
- (2012) J. Ross Chapman et al. MOLECULAR CELL
- RNA therapeutics: beyond RNA interference and antisense oligonucleotides
- (2012) Ryszard Kole et al. NATURE REVIEWS DRUG DISCOVERY
- Exon and intron definition in pre-mRNA splicing
- (2012) Laura De Conti et al. Wiley Interdisciplinary Reviews-RNA
- Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum
- (2011) Liutao Du et al. HUMAN MOLECULAR GENETICS
- Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia
- (2011) Kotoka Nakamura et al. HUMAN MUTATION
- Delayed Postnatal Loss of P/Q-Type Calcium Channels Recapitulates the Absence Epilepsy, Dyskinesia, and Ataxia Phenotypes of Genomic Cacna1A Mutations
- (2011) M. D. Mark et al. JOURNAL OF NEUROSCIENCE
- New mutation of CACNA1A gene in episodic ataxia type 2
- (2011) Koki Nikaido et al. PEDIATRICS INTERNATIONAL
- Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging
- (2011) F. G. Osorio et al. Science Translational Medicine
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
- (2010) Y. Hua et al. GENES & DEVELOPMENT
- Combination of SMN Trans-Splicing and a Neurotrophic Factor Increases the Life Span and Body Mass in a Severe Model of Spinal Muscular Atrophy
- (2010) Monir Shababi et al. HUMAN GENE THERAPY
- Congenital Ataxia, Mental Retardation, and Dyskinesia Associated With a Novel CACNA1A Mutation
- (2010) Lubov Blumkin et al. JOURNAL OF CHILD NEUROLOGY
- Trans-Splicing-Mediated Improvement in a Severe Mouse Model of Spinal Muscular Atrophy
- (2010) T. H. Coady et al. JOURNAL OF NEUROSCIENCE
- Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy
- (2010) Sanjeev Rajakulendran et al. JOURNAL OF PHYSIOLOGY-LONDON
- Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2
- (2010) Elide Mantuano et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel CaV2.1 single amino acid substitution R2090Q
- (2010) Nico Melzer et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Opioid inhibition of N-type Ca2+ channels and spinal analgesia couple to alternative splicing
- (2010) Arturo Andrade et al. NATURE NEUROSCIENCE
- Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients
- (2010) A.T.J.M. Helderman-van den Enden et al. NEUROMUSCULAR DISORDERS
- CaV2.1 channelopathies
- (2010) Daniela Pietrobon PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- The Spliceosome: Design Principles of a Dynamic RNP Machine
- (2009) Markus C. Wahl et al. CELL
- Ribonuclease H: the enzymes in eukaryotes
- (2009) Susana M. Cerritelli et al. FEBS Journal
- Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing
- (2009) T. Rodriguez-Martin et al. HUMAN MOLECULAR GENETICS
- Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations
- (2009) Annemieke Aartsma-Rus et al. HUMAN MUTATION
- Episodic ataxia type 2: unusual aspects in clinical and genetic presentation. Special emphasis in childhood
- (2009) P Bertholon et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene
- (2009) Ester Cuenca-León et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cystic fibrosis
- (2009) Brian P O'Sullivan et al. LANCET
- Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
- (2009) Katharine Bushby et al. LANCET NEUROLOGY
- Alternative splicing and disease
- (2008) Jamal Tazi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Episodic ataxia type 2 showing ictal hyperhidrosis with hypothermia and interictal chronic diarrhea due to a novel CACNA1A mutation
- (2008) D.I. Zafeiriou et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Benign paroxysmal tonic upgaze, benign paroxysmal torticollis, episodic ataxia and CACNA1A mutation in a family
- (2008) A. Roubertie et al. JOURNAL OF NEUROLOGY
- Spinal muscular atrophy
- (2008) Mitchell R Lunn et al. LANCET
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
- Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
- (2008) Qun Pan et al. NATURE GENETICS
- Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2
- (2008) Tracey D. Graves et al. NEUROBIOLOGY OF DISEASE
- Stepwise Developmental Regression Associated With Novel CACNA1A Mutation
- (2008) Andrea A. Guerin et al. PEDIATRIC NEUROLOGY
- Development of a Single Vector System that Enhances Trans-Splicing of SMN2 Transcripts
- (2008) Tristan H. Coady et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started